According to Elevance Health's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.65173. At the end of 2023 the company had a P/S ratio of 0.6796.
Year | P/S ratio | Change |
---|---|---|
2023 | 0.6796 | -13.56% |
2022 | 0.7862 | -2.74% |
2021 | 0.8084 | 25.02% |
2020 | 0.6466 | -11.79% |
2019 | 0.7330 | -0.13% |
2018 | 0.7339 | 14.38% |
2017 | 0.6416 | 43.77% |
2016 | 0.4463 | -3.02% |
2015 | 0.4602 | 0.9% |
2014 | 0.4561 | 19.55% |
2013 | 0.3815 | 26.83% |
2012 | 0.3008 | -20.76% |
2011 | 0.3796 | 3.93% |
2010 | 0.3653 | -9.41% |
2009 | 0.4032 | 17.61% |
2008 | 0.3428 | -55.92% |
2007 | 0.7777 | -8.55% |
2006 | 0.8504 | -27.39% |
2005 | 1.17 | -29.95% |
2004 | 1.67 | 171.64% |
2003 | 0.6155 | -6.72% |
2002 | 0.6598 |